IPO News Archive

Biotech company Codexis withdraws IPO

9/3/08


Codexis, a leading developer of biocatalysts for chemistry-based manufacturing applications in the pharmaceutical and biofuel industries, withdrew its IPO on Wednesday in a filing citing unfavorable market conditions. The company planned to list its shares on the NASDAQ under the ticker CDXS, but deal terms had not been announced. Credit Suisse and Goldman Sachs were set to be the lead underwriters on the deal.

View IPO Profile: CDXS         
Related Links: Postponed & Withdrawn
Source: www.RenaissanceCapital.com
Latest User Comments
a "green" ipo 4/20/2010 5:16:42 PM
Posted by: Opul
Codexis seems to be attracting some attention as a "green" IPO, and comp Amyris Biotechnologies just filed for an IPO this week. It will be interesting to see how it does on the first day with such a...
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital, Greenwich, CT (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital and/or the IPO Plus Fund (symbol: IPOSX) may have investments in securities of companies mentioned.
Invest in the IPO Plus Fund
About Fund Prospectus Invest